Sequoia leads digital therapeutics company Biofourmis' $35M round

Biofourmis raised $35 million in a series B round to develop its AI-powered digital therapeutics platform for improving patient outcomes.

The platform uses AI, drug intervention, wearable sensors and a smartphone app to remotely monitor and analyze a patient's physiological signals, and then predict and prevent adverse events before they occur...